ClearPoint Neuro (CLPT) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

ClearPoint Neuro Revenue Highlights

Latest Revenue (Y)

$36.97M

Latest Revenue (Q)

$8.86M

Main Segment (Y)

Biologics and Drug Delivery Revenue

ClearPoint Neuro Revenue by Period

ClearPoint Neuro Revenue by Year

Date	Revenue	Change
2025-12-31	$36.97M	17.78%
2024-12-31	$31.39M	31.04%
2023-12-31	$23.95M	16.56%
2022-12-31	$20.55M	26.09%
2021-12-31	$16.30M	27.05%
2020-12-31	$12.83M	14.37%
2019-12-31	$11.22M	52.54%
2018-12-31	$7.35M	-0.36%
2017-12-31	$7.38M	28.35%
2016-12-31	$5.75M	25.15%
2015-12-31	$4.59M	27.46%
2014-12-31	$3.60M	-8.30%
2013-12-31	$3.93M	-22.29%
2012-12-31	$5.06M	32.48%
2011-12-31	$3.82M	43.03%
2010-12-31	$2.67M	-

ClearPoint Neuro generated $36.97M in revenue during NA 2025, up 17.78% compared to the previous quarter, and up 288.18% compared to the same period a year ago.

ClearPoint Neuro Revenue by Quarter

Date	Revenue	Change
2025-09-30	$8.86M	-3.84%
2025-06-30	$9.21M	8.60%
2025-03-31	$8.48M	9.19%
2024-12-31	$7.77M	-4.32%
2024-09-30	$8.12M	3.36%
2024-06-30	$7.86M	2.87%
2024-03-31	$7.64M	12.17%
2023-12-31	$6.81M	18.19%
2023-09-30	$5.76M	-3.16%
2023-06-30	$5.95M	9.52%
2023-03-31	$5.43M	5.01%
2022-12-31	$5.17M	0.54%
2022-09-30	$5.15M	-1.04%
2022-06-30	$5.20M	3.36%
2022-03-31	$5.03M	17.49%
2021-12-31	$4.28M	-6.38%
2021-09-30	$4.57M	34.02%
2021-06-30	$3.41M	-15.31%
2021-03-31	$4.03M	8.45%
2020-12-31	$3.72M	5.60%
2020-09-30	$3.52M	42.01%
2020-06-30	$2.48M	-20.47%
2020-03-31	$3.12M	-2.95%
2019-12-31	$3.21M	9.67%
2019-09-30	$2.93M	12.32%
2019-06-30	$2.61M	5.41%
2019-03-31	$2.47M	8.61%
2018-12-31	$2.28M	25.98%
2018-09-30	$1.81M	9.76%
2018-06-30	$1.65M	1.41%
2018-03-31	$1.62M	-3.34%
2017-12-31	$1.68M	-2.20%
2017-09-30	$1.72M	-13.10%
2017-06-30	$1.98M	-1.55%
2017-03-31	$2.01M	22.75%
2016-12-31	$1.64M	1.16%
2016-09-30	$1.62M	46.42%
2016-06-30	$1.10M	-20.82%
2016-03-31	$1.39M	-7.77%
2015-12-31	$1.51M	21.28%
2015-09-30	$1.25M	50.95%
2015-06-30	$825.74K	-18.28%
2015-03-31	$1.01M	5.27%
2014-12-31	$959.84K	51.58%
2014-09-30	$633.20K	-46.74%
2014-06-30	$1.19M	44.54%
2014-03-31	$822.53K	-30.08%
2013-12-31	$1.18M	26.84%
2013-09-30	$927.46K	64.88%
2013-06-30	$562.49K	-55.51%
2013-03-31	$1.26M	-32.13%
2012-12-31	$1.86M	64.57%
2012-09-30	$1.13M	4.44%
2012-06-30	$1.08M	10.59%
2012-03-31	$980.00K	-15.82%
2011-12-31	$1.16M	0.80%
2011-09-30	$1.15M	59.76%
2011-06-30	$722.89K	-

ClearPoint Neuro generated $8.86M in revenue during Q3 2025, up -3.84% compared to the previous quarter, and up 112.76% compared to the same period a year ago.

ClearPoint Neuro Revenue Breakdown

ClearPoint Neuro Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Capital Equipment and Software Revenue	$3.10M	$3.79M	$1.83M	$2.31M	$1.43M
Biologics and Drug Delivery - Disposable Products	$7.34M	$5.61M	$2.15M	$3.69M	$3.35M
Biologics and Drug Delivery Revenue	$19.04M	$17.31M	$13.60M	$9.12M	$6.79M
Capital Equipment and Software - Services	$1.41M	$1.06M	$973.00K	$795.00K	$569.00K
Capital Equipment and Software - Systems and Software Products	$1.69M	$2.73M	$860.00K	$1.51M	$864.00K
Functional Neurosurgery Navigation and Therapy - Disposable Products	-	-	$7.59M	$7.59M	$7.70M
Functional Neurosurgery Navigation and Therapy	-	-	$8.52M	$9.12M	$8.07M
Functional Neurosurgery Navigation and Therapy - Services	-	-	$931.00K	$1.54M	$375.00K
Biologics and Drug Delivery - Services	-	-	-	-	$3.44M

ClearPoint Neuro's latest annual revenue breakdown by segment (product or service), as of Dec 25: Biologics and Drug Delivery Revenue (58.44%), Biologics and Drug Delivery - Disposable Products (22.52%), Capital Equipment and Software Revenue (9.52%), Capital Equipment and Software - Systems and Software Products (5.19%), and Capital Equipment and Software - Services (4.33%).

Quarterly Revenue by Product

Product/Service	Sep 25	Jun 25	Mar 25	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Capital Equipment And Software - Systems and Software Products	$647.00K	$694.00K	$234.00K	$552.00K	$1.16M	$81.00K	$173.00K	$178.00K	$287.00K	$434.00K	$450.00K	-	-	-	-	-	-	-	-	-
Biologics And Drug Delivery	$4.40M	$4.74M	$4.69M	$4.43M	$4.31M	$3.49M	$3.37M	$2.68M	$2.25M	$2.41M	$2.15M	-	-	-	-	-	-	-	-	-
Biologics And Drug Delivery - Disposable Products	$1.29M	$1.87M	$1.78M	$2.06M	$553.00K	$455.00K	$346.00K	$594.00K	$798.00K	$1.23M	$850.00K	-	-	-	-	-	-	-	-	-
Capital Equipment And Software	$1.04M	$1.04M	$517.00K	$831.00K	$1.41M	$357.00K	$381.00K	$396.00K	$480.00K	$619.00K	$639.00K	-	-	-	-	-	-	-	-	-
Capital Equipment And Software - Services	$390.00K	$350.00K	$283.00K	$279.00K	$250.00K	$276.00K	$208.00K	$218.00K	$193.00K	$185.00K	$189.00K	-	-	-	-	-	-	-	-	-
Functional Neurosurgery Navigation and Therapy - Services	-	-	-	-	-	$1.00K	$44.00K	$383.00K	$503.00K	$375.00K	$375.00K	$375.00K	-	-	-	-	-	-	-	-
Functional Neurosurgery Navigation and Therapy	-	-	-	-	$1.93M	$2.04M	$1.92M	$2.20M	$2.36M	$2.42M	$2.17M	$2.24M	$2.14M	-	-	-	-	-	-	-
Functional Neurosurgery Navigation and Therapy - Disposable Products	-	-	-	-	$1.93M	$2.04M	$1.87M	$1.82M	$1.86M	$2.04M	$1.80M	$1.86M	-	-	-	-	-	-	-	-
Biologics And Drug Delivery - Services	-	-	-	-	-	-	-	-	-	$1.45M	$1.18M	$1.30M	-	-	-	-	-	-	-	-
Biologics and Drug Delivery - Disposable Products	-	-	-	-	-	-	-	-	-	-	-	-	$852.00K	-	-	-	-	-	-	-
Biologics and Drug Delivery - Services	-	-	-	-	-	-	-	-	-	-	-	-	$837.00K	-	-	-	-	-	-	-
Biologics and Drug Delivery Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$1.69M	$1.66M	-	-	-	-	-	-
Capital Equipment and Software - Services	-	-	-	-	-	-	-	-	-	-	-	-	$170.00K	-	-	-	-	-	-	-
Capital Equipment and Software - Systems and Software Products	-	-	-	-	-	-	-	-	-	-	-	-	$284.00K	-	-	-	-	-	-	-
Capital Equipment and Software Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$454.00K	$453.00K	-	-	-	-	-	-
Remaining Performance Obligations Capital Equipment-Related Service Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$800.00K	-	$-320.00K	$992.00K	-	-	-
Capital Equipment Related Service Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$100.00K	$90.00K	-	-	-	-	-
Capital Equipment-Related Service Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$217.00K	$89.00K	$121.00K	-
Capital Equipment and Software Revenue Subtotal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$204.56K	-	-
Biologics and Drug Delivery Revenue Subtotal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.47M	-	-
Therapy Revenue Subtotal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$103.80K	-	-

ClearPoint Neuro's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Biologics And Drug Delivery (56.67%), Biologics And Drug Delivery - Disposable Products (16.63%), Capital Equipment And Software (13.35%), Capital Equipment And Software - Systems and Software Products (8.33%), and Capital Equipment And Software - Services (5.02%).

ClearPoint Neuro Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SNDL	SNDL	$909.01M	$197.75M
VREX	Varex Imaging	$844.60M	$209.60M
AVNS	Avanos Medical	$701.20M	$177.80M
AKBA	Akebia Therapeutics	$236.20M	$58.77M
CTKB	Cytek Biosciences	$201.49M	$52.29M
SIBN	SI-BONE	$200.93M	$48.66M
SRDX	Surmodics	$126.08M	$28.09M
LAB	Standard BioTools	$85.33M	$19.55M
CLPT	ClearPoint Neuro	$36.97M	$8.86M
OFIX	Orthofix Medical	-	$205.63M
CMPS	COMPASS Pathways	-	-

CLPT Revenue FAQ

What is ClearPoint Neuro’s yearly revenue?

ClearPoint Neuro's yearly revenue for 2025 was $36.97M, representing an increase of 17.78% compared to 2024. The company's yearly revenue for 2024 was $31.39M, representing an increase of 31.04% compared to 2023. CLPT's yearly revenue for 2023 was $23.96M, representing an increase of 16.56% compared to 2022.

What is ClearPoint Neuro’s quarterly revenue?

ClearPoint Neuro's quarterly revenue for Q3 2025 was $8.86M, a -3.84% decrease from the previous quarter (Q2 2025), and a 9.10% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $9.22M, a 8.60% increase from the previous quarter (Q1 2025), and a 17.27% increase year-over-year (Q2 2024). CLPT's quarterly revenue for Q1 2025 was $8.48M, a 9.19% increase from the previous quarter (Q4 2024), and a 11.07% increase year-over-year (Q1 2024).

What is ClearPoint Neuro’s revenue growth rate?

ClearPoint Neuro's revenue growth rate for the last 3 years (2023-2025) was 54.34%, and for the last 5 years (2021-2025) was 126.83%.

What are ClearPoint Neuro’s revenue streams?

ClearPoint Neuro's revenue streams in c 25 are Capital Equipment and Software Revenue, Biologics and Drug Delivery - Disposable Products, Biologics and Drug Delivery Revenue, Capital Equipment and Software - Services, and Capital Equipment and Software - Systems and Software Products. Capital Equipment and Software Revenue generated $3.1M in revenue, accounting 9.52% of the company's total revenue, down -18.31% year-over-year. Biologics and Drug Delivery - Disposable Products generated $7.34M in revenue, accounting 22.52% of the company's total revenue, up 30.90% year-over-year. Biologics and Drug Delivery Revenue generated $19.04M in revenue, accounting 58.44% of the company's total revenue, up 9.99% year-over-year. Capital Equipment and Software - Services generated $1.41M in revenue, accounting 4.33% of the company's total revenue, up 33.02% year-over-year. Capital Equipment and Software - Systems and Software Products generated $1.69M in revenue, accounting 5.19% of the company's total revenue, down -38.21% year-over-year.

What is ClearPoint Neuro’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of ClearPoint Neuro was Biologics and Drug Delivery Revenue. This segment made a revenue of $19.04M, representing 58.44% of the company's total revenue.